EPIFRIN 1/2% DIN 00001090
Status: Cancelled Post Market
Holder: ALLERGAN INC
Health Canada record
| Active ingredient(s) | EPINEPHRINE RACEMIC (RACEMIC EPINEPHRINE HYDROCHLORIDE) 0.5 % |
|---|---|
| Dosage form | Drops |
| Route | Ophthalmic |
| Schedule | ETHICAL |
| Class | Human |
| ATC | S01EA01 EPINEPHRINE |
| Original market date | 31-Dec-1970 |
| Current status date | 26-Jan-2010 |
| Source | Health Canada DPD |
Establishment licence of the holder
Allergan Sales, LLC — licence , not currently licensed, last inspection rating C (2025-04-21).
No Canadian shortage report is currently matched to this DIN.
Other Canadian products containing EPINEPHRINE RACEMIC (RACEMIC EPINEPHRINE HYDROCHLORIDE)
| DIN | Product | Company | Form | Strength | Status |
|---|---|---|---|---|---|
| 00001104 | EPIFRIN 1% | ALLERGAN INC | Drops | EPINEPHRINE RACEMIC (RACEMIC EPINEPHRINE HYDROCHLORIDE) 1 % | Cancelled Post Market |
| 00001112 | EPIFRIN 2% | ALLERGAN INC | Drops | EPINEPHRINE RACEMIC (RACEMIC EPINEPHRINE HYDROCHLORIDE) 2 % | Cancelled Post Market |
| 00243604 | EPINEPHRINE INJ 1:10000 STERILE | INTERNATIONAL MEDICATION SYSTEMS LTD. | Liquid | EPINEPHRINE RACEMIC (RACEMIC EPINEPHRINE HYDROCHLORIDE) 0.1 MG | Cancelled Post Market |